Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Boot E, Butcher NJ, Udow S, Marras C, Mok KY, Kaneko S, Barrett MJ, Prontera P, Berman BD, Masellis M, Dufournet B, Nguyen K, Charles P, Mutez E, Danaila T, Jacquette A, Colin O, Drapier S, Borg M, Fiksinski AM, Vergaelen E, Swillen A, Vogels A, Plate A, Perandones C, Gasser T, Clerinx K, Bourdain F, Mills K, Williams NM, Wood NW, Booij J, Lang AE, Bassett AS; International Research Group on 22q11.2DS-associated Parkinson's Disease.

Neurology. 2018 May 11. pii: 10.1212/WNL.0000000000005660. doi: 10.1212/WNL.0000000000005660. [Epub ahead of print]

PMID:
29752303
2.

Heritability estimates of cortical anatomy: The influence and reliability of different estimation strategies.

Patel S, Patel R, Park MTM, Masellis M, Knight J, Chakravarty MM.

Neuroimage. 2018 May 6. pii: S1053-8119(18)30412-9. doi: 10.1016/j.neuroimage.2018.05.014. [Epub ahead of print]

PMID:
29742386
3.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

PMID:
29724592
4.

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease.

Dilliott AA, Farhan SMK, Ghani M, Sato C, Liang E, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, Bulman DE, Rogaeva E, Lang A, Tartaglia C, Finger E, Zinman L, Turnbull J, Freedman M, Swartz R, Black SE, Hegele RA.

J Vis Exp. 2018 Apr 4;(134). doi: 10.3791/57266.

5.

Association between maternal childhood maltreatment and mother-infant attachment disorganization: Moderation by maternal oxytocin receptor gene and cortisol secretion.

Ludmer JA, Gonzalez A, Kennedy J, Masellis M, Meinz P, Atkinson L.

Horm Behav. 2018 Apr 24;102:23-33. doi: 10.1016/j.yhbeh.2018.04.006. [Epub ahead of print]

PMID:
29673618
6.

Age representation in antiepileptic drug trials: A systematic review and meta-analysis.

Desmarais P, Miville C, Milán-Tomás Á, Nguyen QD, Ojeda-López C, Masellis M, Black SE, Andrade DM, Herrmann N.

Epilepsy Res. 2018 May;142:9-15. doi: 10.1016/j.eplepsyres.2018.03.005. Epub 2018 Mar 6.

PMID:
29544171
7.

Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.

Schneider R, McKeever P, Kim T, Graff C, van Swieten JC, Karydas A, Boxer A, Rosen H, Miller BL, Laforce R Jr, Galimberti D, Masellis M, Borroni B, Zhang Z, Zinman L, Rohrer JD, Tartaglia MC, Robertson J; Genetic FTD Initiative (GENFI).

J Neurol Neurosurg Psychiatry. 2018 Feb 6. pii: jnnp-2017-317492. doi: 10.1136/jnnp-2017-317492. [Epub ahead of print]

8.

The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy.

Swardfager W, Cogo-Moreira H, Masellis M, Ramirez J, Herrmann N, Edwards JD, Saleem M, Chan P, Yu D, Nestor SM, Scott CJM, Holmes MF, Sahlas DJ, Kiss A, Oh PI, Strother SC, Gao F, Stefanovic B, Keith J, Symons S, Swartz RH, Lanctôt KL, Stuss DT, Black SE.

Neurology. 2018 Feb 20;90(8):e673-e682. doi: 10.1212/WNL.0000000000004983. Epub 2018 Jan 26.

PMID:
29374101
9.

Comment: Unraveling DNA sequence to identify cerebral indicators of dementia risk.

Masellis M, Knight J.

Neurology. 2018 Jan 16;90(3):109. doi: 10.1212/WNL.0000000000004838. Epub 2017 Dec 27. No abstract available.

PMID:
29282334
10.

Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.

Cash DM, Bocchetta M, Thomas DL, Dick KM, van Swieten JC, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni GB, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Rossor MN, Ourselin S, Rohrer JD; Genetic FTD Initiative, GENFI.

Neurobiol Aging. 2018 Feb;62:191-196. doi: 10.1016/j.neurobiolaging.2017.10.008. Epub 2017 Oct 19.

11.

Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.

Galimberti D, Fumagalli GG, Fenoglio C, Cioffi SMG, Arighi A, Serpente M, Borroni B, Padovani A, Tagliavini F, Masellis M, Tartaglia MC, van Swieten J, Meeter L, Graff C, de Mendonça A, Bocchetta M, Rohrer JD, Scarpini E; Genetic FTD Initiative (GENFI).

Neurobiol Aging. 2018 Feb;62:245.e9-245.e12. doi: 10.1016/j.neurobiolaging.2017.10.016. Epub 2017 Nov 13.

12.

Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness.

Finger E, Zhang J, Dickerson B, Bureau Y, Masellis M; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;60(3):1161-1170. doi: 10.3233/JAD-170348.

PMID:
28984590
13.

Unraveling PINK1 regulation: Ubiquitination of its mature form and insights for Parkinson's disease.

Saeed U, Masellis M.

Mov Disord. 2017 Nov;32(11):1546. doi: 10.1002/mds.27171. Epub 2017 Oct 4. No abstract available.

PMID:
28976028
14.

Sex differences in the prevalence of genetic mutations in FTD and ALS: A meta-analysis.

Curtis AF, Masellis M, Hsiung GR, Moineddin R, Zhang K, Au B, Millett G, Mackenzie I, Rogaeva E, Tierney MC.

Neurology. 2017 Oct 10;89(15):1633-1642. doi: 10.1212/WNL.0000000000004494. Epub 2017 Sep 15. Review.

PMID:
28916533
15.

Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration.

Espay AJ, Da Prat GA, Dwivedi AK, Rodriguez-Porcel F, Vaughan JE, Rosso M, Devoto JL, Duker AP, Masellis M, Smith CD, Mandybur GT, Merola A, Lang AE.

Ann Neurol. 2017 Oct;82(4):503-513. doi: 10.1002/ana.25046. Epub 2017 Oct 4. Review.

PMID:
28892572
16.

Maternal DRD2, SLC6A3, and OXTR genotypes as potential moderators of the relation between maternal history of care and maternal cortisol secretion in the context of mother-infant separation.

Ludmer JA, Jamieson B, Gonzalez A, Levitan R, Kennedy J, Villani V, Masellis M, Basile VS, Atkinson L.

Biol Psychol. 2017 Oct;129:154-164. doi: 10.1016/j.biopsycho.2017.09.004. Epub 2017 Sep 7.

PMID:
28890000
17.

Dopamine receptor D2 (DRD2), dopamine transporter solute carrier family C6, member 4 (SLC6A3), and catechol-O-methyltransferase (COMT) genes as moderators of the relation between maternal history of maltreatment and infant emotion regulation.

Villani V, Ludmer J, Gonzalez A, Levitan R, Kennedy J, Masellis M, Basile VS, Wekerle C, Atkinson L.

Dev Psychopathol. 2018 May;30(2):581-592. doi: 10.1017/S0954579417001122. Epub 2017 Aug 14.

PMID:
28803562
18.

Peripheral lipid oxidative stress markers are related to vascular risk factors and subcortical small vessel disease.

Swardfager W, Yu D, Scola G, Cogo-Moreira H, Chan P, Zou Y, Herrmann N, Lanctôt KL, Ramirez J, Gao F, Masellis M, Swartz RH, Sahlas DJ, Chan PC, Ojeda-Lopez C, Milan-Tomas A, Pettersen JA, Andreazza AC, Black SE.

Neurobiol Aging. 2017 Nov;59:91-97. doi: 10.1016/j.neurobiolaging.2017.06.029. Epub 2017 Jul 11.

PMID:
28756941
19.

Social inappropriateness in neurodegenerative disorders.

Desmarais P, Lanctôt KL, Masellis M, Black SE, Herrmann N.

Int Psychogeriatr. 2018 Feb;30(2):197-207. doi: 10.1017/S1041610217001260. Epub 2017 Jul 10.

PMID:
28689508
20.

Enhancement of automated blood flow estimates (ENABLE) from arterial spin-labeled MRI.

Shirzadi Z, Stefanovic B, Chappell MA, Ramirez J, Schwindt G, Masellis M, Black SE, MacIntosh BJ.

J Magn Reson Imaging. 2018 Mar;47(3):647-655. doi: 10.1002/jmri.25807. Epub 2017 Jul 6.

PMID:
28681479
21.

Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Montero-Odasso M, Pieruccini-Faria F, Bartha R, Black SE, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McLaughlin PM, Munoz DP, Strother S, Swartz RH, Symons S, Tartaglia MC, Zinman L, Strong MJ; ONDRI Investigators, McIlroy W.

J Alzheimers Dis. 2017;59(2):707-721. doi: 10.3233/JAD-170149.

22.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

23.

Heritability of hippocampal subfield volumes using a twin and non-twin siblings design.

Patel S, Park MTM, Devenyi GA, Patel R, Masellis M, Knight J, Chakravarty MM.

Hum Brain Mapp. 2017 Sep;38(9):4337-4352. doi: 10.1002/hbm.23654. Epub 2017 May 31.

PMID:
28561418
24.

White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.

Sudre CH, Bocchetta M, Cash D, Thomas DL, Woollacott I, Dick KM, van Swieten J, Borroni B, Galimberti D, Masellis M, Tartaglia MC, Rowe JB, Graff C, Tagliavini F, Frisoni G, Laforce R Jr, Finger E, de Mendonça A, Sorbi S, Ourselin S, Cardoso MJ, Rohrer JD; Genetic FTD Initiative, GENFI.

Neuroimage Clin. 2017 Apr 26;15:171-180. doi: 10.1016/j.nicl.2017.04.015. eCollection 2017.

25.

Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI).

Mutsaerts HJMM, Petr J, Thomas DL, De Vita E, Cash DM, van Osch MJP, Golay X, Groot PFC, Ourselin S, van Swieten J, Laforce R Jr, Tagliavini F, Borroni B, Galimberti D, Rowe JB, Graff C, Pizzini FB, Finger E, Sorbi S, Castelo Branco M, Rohrer JD, Masellis M, MacIntosh BJ; GENFI investigators.

J Magn Reson Imaging. 2018 Jan;47(1):131-140. doi: 10.1002/jmri.25751. Epub 2017 May 8.

PMID:
28480617
26.

Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.

Premi E, Grassi M, van Swieten J, Galimberti D, Graff C, Masellis M, Tartaglia C, Tagliavini F, Rowe JB, Laforce R Jr, Finger E, Frisoni GB, de Mendonça A, Sorbi S, Gazzina S, Cosseddu M, Archetti S, Gasparotti R, Manes M, Alberici A, Cardoso MJ, Bocchetta M, Cash DM, Ourselin S, Padovani A, Rohrer JD, Borroni B; Genetic FTD Initiative (GENFI).

Brain. 2017 Jun 1;140(6):1784-1791. doi: 10.1093/brain/awx103.

27.

Collagenosis of the Deep Medullary Veins: An Underrecognized Pathologic Correlate of White Matter Hyperintensities and Periventricular Infarction?

Keith J, Gao FQ, Noor R, Kiss A, Balasubramaniam G, Au K, Rogaeva E, Masellis M, Black SE.

J Neuropathol Exp Neurol. 2017 Apr 1;76(4):299-312. doi: 10.1093/jnen/nlx009.

PMID:
28431180
28.

Development of cognitive screening test for the severely hearing impaired: Hearing-impaired MoCA.

Lin VY, Chung J, Callahan BL, Smith L, Gritters N, Chen JM, Black SE, Masellis M.

Laryngoscope. 2017 May;127 Suppl 1:S4-S11. doi: 10.1002/lary.26590.

PMID:
28409842
29.

The role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.

Lehericy S, Vaillancourt DE, Seppi K, Monchi O, Rektorova I, Antonini A, McKeown MJ, Masellis M, Berg D, Rowe JB, Lewis SJG, Williams-Gray CH, Tessitore A, Siebner HR; International Parkinson and Movement Disorder Society (IPMDS)-Neuroimaging Study Group.

Mov Disord. 2017 Apr;32(4):510-525. doi: 10.1002/mds.26968. Epub 2017 Mar 28. Review.

PMID:
28370449
30.

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Butcher NJ, Marras C, Pondal M, Rusjan P, Boot E, Christopher L, Repetto GM, Fritsch R, Chow EWC, Masellis M, Strafella AP, Lang AE, Bassett AS.

Brain. 2017 May 1;140(5):1371-1383. doi: 10.1093/brain/awx053.

PMID:
28369257
31.

Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.

Saeed U, Compagnone J, Aviv RI, Strafella AP, Black SE, Lang AE, Masellis M.

Transl Neurodegener. 2017 Mar 28;6:8. doi: 10.1186/s40035-017-0076-6. eCollection 2017. Review.

32.

Development of a decision-making tool for reporting drivers with mild dementia and mild cognitive impairment to transportation administrators.

Cameron DH, Zucchero Sarracini C, Rozmovits L, Naglie G, Herrmann N, Molnar F, Jordan J, Byszewski A, Tang-Wai D, Dow J, Frank C, Henry B, Pimlott N, Seitz D, Vrkljan B, Taylor R, Masellis M, Rapoport MJ.

Int Psychogeriatr. 2017 Sep;29(9):1551-1563. doi: 10.1017/S1041610217000242. Epub 2017 Mar 22.

PMID:
28325164
33.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

PMID:
28150432
34.

Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.

Nestor SM, Mišić B, Ramirez J, Zhao J, Graham SJ, Verhoeff NPLG, Stuss DT, Masellis M, Black SE.

Alzheimers Dement. 2017 Jul;13(7):749-760. doi: 10.1016/j.jalz.2016.12.007. Epub 2017 Jan 27.

PMID:
28137552
35.

The spatial coefficient of variation in arterial spin labeling cerebral blood flow images.

Mutsaerts HJ, Petr J, Václavů L, van Dalen JW, Robertson AD, Caan MW, Masellis M, Nederveen AJ, Richard E, MacIntosh BJ.

J Cereb Blood Flow Metab. 2017 Sep;37(9):3184-3192. doi: 10.1177/0271678X16683690. Epub 2017 Jan 6.

PMID:
28058975
36.

The Ontario Neurodegenerative Disease Research Initiative (ONDRI).

Farhan SM, Bartha R, Black SE, Corbett D, Finger E, Freedman M, Greenberg B, Grimes DA, Hegele RA, Hudson C, Kleinstiver PW, Lang AE, Masellis M, McIlroy WE, McLaughlin PM, Montero-Odasso M, Munoz DG, Munoz DP, Strother S, Swartz RH, Symons S, Tartaglia MC, Zinman L; ONDRI Investigators, Strong MJ.

Can J Neurol Sci. 2017 Mar;44(2):196-202. doi: 10.1017/cjn.2016.415. Epub 2016 Dec 22.

PMID:
28003035
37.

Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia.

Graham NL, Leonard C, Tang-Wai DF, Black S, Chow TW, Scott CJ, McNeely AA, Masellis M, Rochon E.

Dement Geriatr Cogn Dis Extra. 2016 Sep 23;6(3):407-423. eCollection 2016 Sep-Dec.

38.

Qualitative analysis of emergency department reports applied to a pilot project for the prevention of pediatric burns.

Longo E, Masellis M, Fondi G, Cedri C, Debbia C, Pitidis A.

Ann Burns Fire Disasters. 2015 Dec 31;28(4):247-252.

39.

Characterizing familial corticobasal syndrome due to Alzheimer's disease pathology and PSEN1 mutations.

Lam B, Khan A, Keith J, Rogaeva E, Bilbao J, St George-Hyslop P, Ghani M, Freedman M, Stuss DT, Chow T, Black SE, Masellis M.

Alzheimers Dement. 2017 May;13(5):520-530. doi: 10.1016/j.jalz.2016.08.014. Epub 2016 Oct 12.

PMID:
27743520
40.

The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration.

Farhan SMK, Dilliott AA, Ghani M, Sato C, Liang E, Zhang M, McIntyre AD, Cao H, Racacho L, Robinson JF, Strong MJ, Masellis M, St George-Hyslop P, Bulman DE, Rogaeva E, Hegele RA; ONDRI Investigators.

NPJ Genom Med. 2016 Sep 21;1:16032. doi: 10.1038/npjgenmed.2016.32. eCollection 2016.

41.

'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?

Udow SJ, Robertson AD, MacIntosh BJ, Espay AJ, Rowe JB, Lang AE, Masellis M.

J Neurol Neurosurg Psychiatry. 2016 Dec;87(12):1311-1321. doi: 10.1136/jnnp-2016-314123. Epub 2016 Sep 9. Review.

PMID:
27613160
42.

Neurofilament light chain: a biomarker for genetic frontotemporal dementia.

Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, Ghidoni R, Pijnenburg YA, Borroni B, Galimberti D, Laforce RJ, Masellis M, Vandenberghe R, Ber IL, Otto M, van Minkelen R, Papma JM, Rombouts SA, Balasa M, Öijerstedt L, Jelic V, Dick KM, Cash DM, Harding SR, Jorge Cardoso M, Ourselin S, Rossor MN, Padovani A, Scarpini E, Fenoglio C, Tartaglia MC, Lamari F, Barro C, Kuhle J, Rohrer JD, Teunissen CE, van Swieten JC.

Ann Clin Transl Neurol. 2016 Jul 1;3(8):623-36. doi: 10.1002/acn3.325. eCollection 2016 Aug.

43.

Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets.

Espay AJ, LeWitt PA, Hauser RA, Merola A, Masellis M, Lang AE.

Lancet Neurol. 2016 Aug;15(9):954-966. doi: 10.1016/S1474-4422(16)30079-5. Review.

PMID:
27478953
44.

Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.

Masellis M, Collinson S, Freeman N, Tampakeras M, Levy J, Tchelet A, Eyal E, Berkovich E, Eliaz RE, Abler V, Grossman I, Fitzer-Attas C, Tiwari A, Hayden MR, Kennedy JL, Lang AE, Knight J; ADAGIO investigators.

Brain. 2016 Jul;139(Pt 7):2050-62. doi: 10.1093/brain/aww109. Epub 2016 May 13.

PMID:
27190009
45.

Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE, Kleiner-Fisman G.

PLoS One. 2016 Apr 21;11(4):e0153852. doi: 10.1371/journal.pone.0153852. eCollection 2016. Review.

46.

MATERNAL SELF-REPORTED DEPRESSIVE SYMPTOMS AND MATERNAL CORTISOL LEVELS INTERACT TO PREDICT INFANT CORTISOL LEVELS.

Khoury JE, Gonzalez A, Levitan R, Masellis M, Basile V, Atkinson L.

Infant Ment Health J. 2016 Mar-Apr;37(2):125-39. doi: 10.1002/imhj.21554. Epub 2016 Mar 4.

PMID:
26939829
47.

Summary cortisol reactivity indicators: Interrelations and meaning.

Khoury JE, Gonzalez A, Levitan RD, Pruessner JC, Chopra K, Basile VS, Masellis M, Goodwill A, Atkinson L.

Neurobiol Stress. 2015 Apr 30;2:34-43. doi: 10.1016/j.ynstr.2015.04.002. eCollection 2015.

48.

Editorial.

Masellis M, Gunn SW.

Ann Burns Fire Disasters. 2015 Mar 31;28(1):3. No abstract available.

49.

Orthostatic hypotension, cerebral hypoperfusion, and visuospatial deficits in Lewy body disorders.

Robertson AD, Messner MA, Shirzadi Z, Kleiner-Fisman G, Lee J, Hopyan J, Lang AE, Black SE, MacIntosh BJ, Masellis M.

Parkinsonism Relat Disord. 2016 Jan;22:80-6. doi: 10.1016/j.parkreldis.2015.11.019. Epub 2015 Nov 23.

PMID:
26639982
50.

Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition.

Janik R, Thomason LA, Chaudhary S, Dorr A, Scouten A, Schwindt G, Masellis M, Stanisz GJ, Black SE, Stefanovic B.

Biochim Biophys Acta. 2016 May;1862(5):957-65. doi: 10.1016/j.bbadis.2015.10.023. Epub 2015 Oct 28.

Supplemental Content

Loading ...
Support Center